Come and see the new publication that members of the REMEDY team have contributed to. The publication describes the delay for first-in-minor cancer clinical trials and its relationship with FDA approval.
Bicer S, Hutchinson N, Feldhake E, Nelson A, Oliviero E, Waligóra M, Kimmelman J. Timing for First-in-Minor Clinical Trials of New Cancer Drugs. J Pediatr. 2023 Aug 30:113705.